Last reviewed · How we verify

NCT03551366: SAMPLE-PE

Influence of Different Physical Education Pedagogical Approaches on the Health and Development of 5-6 Year Old Children

Completed NA Last updated 14 August 2019
What this trial tests

NA trial testing Linear in Child in 361 participants. Completed in 13 August 2019.

Timeline
4 January 2018
Primary endpoint
30 March 2019
13 August 2019

Quick facts

Lead sponsorLiverpool John Moores University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeother
Enrollment361
Start date4 January 2018
Primary completion30 March 2019
Estimated completion13 August 2019
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

Liverpool John Moores University

Who can join

Adults 5 to 6, any sex, with Child or Child Development. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The Skill Acquisition Methods underpinning Pedagogy for LEarning in Physical Education (SAMPLE-PE) project aims to investigate the influence of different pedagogical approaches to teaching and learning in physical education (PE) on 5-6 year old children's health and development. Schools from deprived areas are invited to take part in the project and will be randomly assigned to either: (1) linear pedagogy PE curriculum programme, (2) nonlinear pedagogy PE curriculum programme or (3) carry on as normal. The linear and nonlinear pedagogy PE programmes will be underpinned by different and contrasting theories of skill acquisition and are delivered by trained coaches over 15 weeks. Children will be measured to assess their physical, psychological, cognitive, and emotional health and development, and their physical activity levels at the start of the study, immediately after the 15 week PE programme, and again after 12 months. It is expected that children taking part in the linear and nonlinear PE programmes will demonstrate greater physical development than children attending schools that carry on as normal. Furthermore, it is also anticipated that children taking part in the nonlinear PE programme will show greater gains in psychological, cognitive and emotional outcomes than the linear and usual practice programmes.

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Skill Acquisition Methods Fostering Physical Literacy in Early-Physical Education (SAMPLE-PE): Rationale and Study Protocol for a Cluster Randomized Controlled Trial in 5-6-Year-Old Children From Deprived Areas of North West England.
    Rudd JR, Crotti M, Fitton-Davies K, O'Callaghan L, et al · · 2020 · cited 25× · PMID 32625143 · DOI 10.3389/fpsyg.2020.01228
  2. Strategies for enhancing the implementation of school-based policies or practices targeting diet, physical activity, obesity, tobacco or alcohol use.
    Lee DC, O'Brien KM, McCrabb S, Wolfenden L, et al · · 2024 · cited 11× · PMID 39665378 · DOI 10.1002/14651858.cd011677.pub4
  3. Effect of Linear and Nonlinear Pedagogy Physical Education Interventions on Children's Physical Activity: A Cluster Randomized Controlled Trial (SAMPLE-PE).
    Crotti M, Rudd JR, Roberts S, Boddy LM, et al · · 2021 · cited 9× · PMID 33467568 · DOI 10.3390/children8010049
  4. Physical activity promoting teaching practices and children's physical activity within physical education lessons underpinned by motor learning theory (SAMPLE-PE).
    Crotti M, Rudd J, Roberts S, Fitton Davies K, et al · · 2022 · cited 4× · PMID 35913904 · DOI 10.1371/journal.pone.0272339

Verify or expand the search:

Other recruiting trials for Child

Currently open trials in the same condition.

Other Liverpool John Moores University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03551366.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing